The Arora Report

Rss Facebook Twitter Linkedin

Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

UPDATE ON JPMORGAN AFTER EARNINGS, BEAUTY OF THE BUY ZONES ON VIVID DISPLAY $JPM

July 14, 2017

This post was just published on ZYX Buy Change Alert.   JPM is long from $34.14.  As of this writing JPM is trading at $91.52. Earnings JPM reported earnings better than the consensus and better than the whisper number.  All in all the earnings are very positive. Stock Pulls Back The stock is pulling back on good earnings.  It is simply ‘buy the rumor sell the news’ reaction. Beauty Of The Buy Zone On Display Beauty of the buy zones is on vivid display in JPM.  Back in March 2017, JPM was approaching $94.  There was an influx of new subscribers including

Read More »

WEEKLY MARKET DIGEST: NO IMMEDIATE DANGER FROM FED UNWINDING, PROBLEMS IN 2019, PLAN TO MAKE MONEY FROM UNWINDING $DIA $GLD $QQQ $SLV $SPY $USO

July 14, 2017

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section What To Do Now. GOLD AND BONDS ROAR AS DOLLAR SLUMPS ON WEAK INFLATION AND RETAIL SALES DATA; OIL RALLIES ON NIGERIA July 14, 2017 This is what you need

Read More »

UNUSUAL BULLISH OPTION ACTIVITY IN GENERAL ELECTRIC $GE

July 13, 2017

This post was just published on ZYX Buy Change Alert. After days of negative sentiment, today there is unusual bullish option activity in GE. August 28 calls were swept from the exchange this morning with a volume of 5K for $0.20 each.  Subsequently 10K more calls were swept at $0.23. GE will report earnings on July 21st.  Considering the sentiment around the stock, earnings pose a high risk both to the upside and the downside.  The stock can easily go up 15 – 20% or go down 10- 15% after earnings. The present position is 25% of the full core position size. 

Read More »

STOCKS COULD CRASH IF THE FED’S YELLEN CAN’T PERFORM A MIRACLE $SPY $QQQ $IWM $GLD $SLV $GDX $TBF $TBT $TLT

July 13, 2017

Investors have bought into what some bankers have been calling the “immaculate conception” thought up by a group of humans led by Federal Reserve Chairwoman Janet Yellen. Does anyone see the danger to their money in believing that Fed policy makers can pull off such a miracle? The miracle, of course, is draining trillions of dollars in liquidity from the financial system without causing harm to the economy or securities. A chart Please click here to see a chart of the Fed’s total assets. Notice how they ballooned from under $1 trillion to $4.5 trillion. The continued excitement in the

Read More »

TAKE PARTIAL PROFITS ON FLEXION THERAPEUTICS $FLXN

July 13, 2017

This post was just published on ZYX Buy Change Alert.  FLXN is long from 18.75.  The stock is trading at $23.19 as of this writing.  The original thesis remains intact. The new target zone is $38 to $44.  However, there are many very near term risks that could cause the stock to pull back.  Please remember this is a biotech stock and biotech stocks can be very volatile. Consider taking partial profits on a 10% tranche right here and consider continuing to hold the remaining 10% as part of your speculative portfolio. A special note to new subscribers: Please see Trade Management

Read More »

A NEW FEAR OF TRUMP IMPEACHMENT COULD MOVE STOCKS, BONDS AND GOLD $GLD $NVDA $AMZN $TSLA $AAPL $QQQ $SPY $IWM $TLT $SLV $GOOG $FB $NFLX

July 11, 2017

Successful investors make money by preparing for scenarios without letting their politics cloud their judgement. That’s a difficult task, especially in these partisan times. But I am politically agnostic, and I see my job as helping other investors. The chart To understand the new development today, let us look at an annotated chart. The chart is of the Nasdaq 100 ETF QQQ.  Similar action can be seen in the charts of the S&P 500 ETF SPY, small-cap ETF IWM,  bond ETF TLT, gold ETF GLD, and silver ETF SLV. The reason I picked QQQ is because it has heavy weighting

Read More »

INTELLIGENCE: AMICUS THERAPUTICS JUMPS 23%, SEVEN POTENTIAL BIOTECH BUYOUT TARGETS $FOLD $BMRN $EXEL $INCY $MDVN $RARE $SGEN $TSRO

July 11, 2017

This post was just published on ZYX Buy Change Alert. FOLD plans to submit a new drug application to FDA for the oral precision medicine migalastat for Fabry disease.  The stock is jumping on the news. We are not recommending buying FOLD here but it can be part of a basket on a pullback as discussed below. Based on questions you are asking us, we are republishing the prior post here: INTELLIGENCE: SEVEN POTENTIAL BIOTECH BUYOUT TARGETS IN WAKE OF ARIA BUYOUT For us to recommend, a stock must pass at least four of the six screens. We prefer a stock to

Read More »

NEW BUY ZONE ON ARENA FOR THOSE NOT IN IT AND NEW TARGETS $ARNA

July 11, 2017

This post was just published on ZYX Buy Change Alert.  New buy zone for those not in ARNA is $20.33 to $22.78.  Maximum position is 20% of the full core position size. New target zone without a buyout is $32 to $34.  In the event of a buyout, a price in the zone of $44 to $52 is possible. Please understand that there is high risk in buying the stock right here without waiting for a pullback. A special note for new subscribers: Please carefully study Trade Management Guidelines for speculative positions, these are the techniques that billionaires and hedge funds use

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content